Mayukh Sukhatme

2022

In 2022, Mayukh Sukhatme earned a total compensation of $48.9M as President and Chief Investment Officer at Roivant Sciences Ltd., a 180% increase compared to previous year.

Compensation breakdown

Bonus$1,243,500
Option Awards$47,206,737
Salary$450,000
Other$25,346
Total$48,925,582

Sukhatme received $47.2M in option awards, accounting for 96% of the total pay in 2022.

Sukhatme also received $1.2M in bonus, $450K in salary and $25.3K in other compensation.

Rankings

In 2022, Mayukh Sukhatme's compensation ranked 13th out of 5,711 executives tracked by ExecPay. In other words, Sukhatme earned more than 99.8% of executives.

ClassificationRankingPercentile
All
13
out of 5,711
100th
Division
Manufacturing
5
out of 3,109
100th
Major group
Chemicals And Allied Products
2
out of 1,410
100th
Industry group
Drugs
2
out of 1,311
100th
Industry
Pharmaceutical Preparations
2
out of 957
100th
Source: SEC filing on July 31, 2023.

Sukhatme's colleagues

We found two more compensation records of executives who worked with Mayukh Sukhatme at Roivant Sciences Ltd. in 2022.

2022

Matthew Gline

Roivant Sciences Ltd.

Chief Executive Officer

2022

Eric Venker

Roivant Sciences Ltd.

Chief Operating Officer

News

In-depth

You may also like